News
CXCL9/10-engineered dendritic cells promote T cell activation and enhance immune checkpoint blockade for lung cancer. Cell Reports Medicine, 2024; 101479 DOI: 10.1016/j.xcrm.2024.101479 ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback